Please note: We are currently experiencing some performance issues across the site, and some pages may be slow to load. We are working on restoring normal service soon. Importing new articles from Word documents is also currently unavailable. We apologize for any inconvenience.

loading page

CRISPR Cas13a: A Potential Therapeutic Cure for HIV Infection in Humans
  • +3
  • Avinash Sharma,
  • Adeeb Ahmad Siddiqui,
  • Akash K,
  • Deepak Kumar,
  • Deepak Kapoor N,
  • Rupak Nagraik
Avinash Sharma
Shoolini University

Corresponding Author:[email protected]

Author Profile
Adeeb Ahmad Siddiqui
Shoolini University
Author Profile
Akash K
Shoolini University
Author Profile
Deepak Kumar
Shoolini University
Author Profile
Deepak Kapoor N
Shoolini University
Author Profile
Rupak Nagraik
Shoolini University
Author Profile

Abstract

Human Immunodeficiency Virus (HIV), is a lethal virus that infects the human immune system. Once the person gets infected with HIV, the infection will gradually lead to AIDS which attacks the immune system and ultimately causes death if proper precautionary measures are not taken against it. Currently, anti-viral therapies and drugs combined with this are utilized by patients diagnosed with HIV. But with rapid mutation capabilities, the virus showcased resistance to the drugs, therefore, pushing the scientific community to explore a more stable and rapid treatment option for HIV. Recently, the utilization of CRISPR Cas technologies for genetic modification, disease diagnosis, disease treatment, and biosensing technologies has greatly increased due to their numerous advantages. This review focuses on the working mechanism of CRISPR Cas13a that is divided into its stages followed by the conventional methods used for HIV treatment, we also highlighted the potential applications that use Cas13 protein for its working principle and finally the usage of Cas13a towards HIV diagnosis, treatment, and prospects of this technology.